AzTrials
AzTrials

Trauma, Nervous SystemSLEEPDOCNCT06766513

Characterization of the Sleep-Wake Cycle in Traumatic Brain Injury Patients with a Disorder of Consciousness

A study testing Actimetry, Subjective assessments and questionnaire in people with Trauma, Nervous System and Brain Trauma, run by Hospices Civils de Lyon at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Each year in France, 160,000 peoples suffer from a mild or severe traumatic brain injury (TBI). Sleep plays a crucial role in the process of brain plasticity, which is essential for neurological and cognitive recovery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Trauma, Nervous System, Brain Trauma
What is being tested?
Actimetry, Subjective assessments and questionnaire
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
1 Feb 2025to 1 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Admission to the Post-Resuscitation Rehabilitation Unit or the Neurological Intensive Care Unit
  • Consciousness disorders: Vegetative State or Minimally Conscious State (according to the CRS-R)
  • Traumatic brain injury
  • Patient aged 18 years or older
  • Presence of relatives able to express non-opposition to the study
  • Subjects affiliated with a social security scheme (or beneficiaries)

Who cannot join

  • Admission for status epilepticus
  • Individuals admitted to a healthcare or social care facility for purposes other than research
  • Adults under legal protection measures (guardianship, conservatorship)
  • Individuals not affiliated with a social security scheme or not benefiting from a similar scheme

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jacques LUAUTE, professor contact

04.78.86.51.87 ext. 33

jacques.luaute@chu-lyon.fr

Anne-Laure CHARLOIS contact

anne-laure.charlois@chu-lyon.fr

France1 site
  • Hôpital Neurologique Pierre Wertheimer, Service de Réanimation Polyvalente Neurologique

    Bron, France, 69500

    Jacques LUAUTE, 04.78.86.51.87 ext. +33, jacques.luaute@chu-lyon.fr

    Jacques LUAUTE

Other trials in France

About this study

Each year in France, 160,000 peoples suffer from a mild or severe traumatic brain injury (TBI). Sleep plays a crucial role in the process of brain plasticity, which is essential for neurological and cognitive recovery. However, the sleep-wake cycle is rarely, if ever, evaluated in patients with TBI and consciousness disorders within Post-Resuscitation Rehabilitation Units (SRPR). Caregivers develop, on a daily basis, an intuitive understanding of the patient's overall condition. This expertise deserves to be validated using objective sleep assessment tools (actigraphy). If proven accurate, it could lead to the implementation of a sleep-wake cycle evaluation protocol within SRPRs.

Being tested
Actimetry, Subjective assessments, questionnaire
Keywords
Traumatic brain injury, Disorders of consciousness, Vegetative State, Minimally Conscious State
Medical subject headings
Trauma, Nervous System, Brain Injuries, Traumatic, Consciousness Disorders, Persistent Vegetative State

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ActimetryOther

    actimetry will be performed continuously during these 104 hours.

  • Subjective assessmentsOther

    The subjective assessments of the patient's awake/sleep state will be collected every 2 hours during the night and at least 3 times during the day, for a total of at least 8 assessments per 24-hour period, over a duration of 104 consecutive hours (slightly more than 4 days, starting at midnight and ending at 8 :00 AM, to cover 4 full days and 4 full nights).

  • questionnaireOther

    MOCA : Montreal Cognitive Assessment

  • questionnaireOther

    SF-36 The Short Form (36)

  • questionnaireOther

    CRS-R (Coma Recovery Scale-Revised)

  • questionnaireOther

    GOSE (Glasgow Outcome Scale-Extended)

  • questionnaireOther

    GCS (Glasgow Coma Scale)

Study groups in NCT06766513
Study groupRoleWhat they receive
Patients in a vegetative stateExperimentalNot described
Receives: Other: Actimetry; Other: Subjective assessments; Other: questionnaire
Patients in a minimally conscious stateExperimentalNot described
Receives: Other: Actimetry; Other: Subjective assessments; Other: questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective assessments

    Measured: during 104 consecutive hours after enrollment

  2. Actimetry

    Measured: during 104 consecutive hours after enrollment

Secondary outcomes (12)
  1. Coma Recovery Scale-Revised

    Measured: once a day for 6 to 5 days

  2. Coma Recovery Scale-Revised

    Measured: 3 months after the start of study

  3. Coma Recovery Scale-Revised

    Measured: 6 months after the start of study

  4. Glasgow Coma Scale assessment

    Measured: once a day for 6 to 5 days

  5. Glasgow Coma Scale assessment

    Measured: 3 months after the start of study

  6. Glasgow Coma Scale assessment

    Measured: 6 months after the start of study

  7. Glasgow Outcome Scale-Extended assessment

    Measured: 6 months after the start of study

  8. Glasgow Outcome Scale-Extended assessment

    Measured: 3 months after the start of study

  9. Montreal Cognitive Assessment

    Measured: 3 months after the start of study

  10. Montreal Cognitive Assessment

    Measured: 6 months after the start of study

  11. Short Form 36 assessment

    Measured: 3 months after the start of the study

  12. Short Form 36 assessment

    Measured: 6 months after the start of study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2025
  2. Study start1 Feb 2025 (estimated)
  3. Primary completion1 Feb 2028 (estimated)
  4. Study completion1 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06766513
Sponsor's protocol ID
69HCL24_0936
Other IDs
2024-A02567-40
Acronym
SLEEPDOC
Status last verified
Jan 2025
First submitted
16 Dec 2024
Last updated
9 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Actimetry, Subjective assessments and questionnaire in people with Trauma, Nervous System and Brain Trauma, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jacques LUAUTE, professor (04.78.86.51.87 ext. 33, jacques.luaute@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective assessments (time frame: during 104 consecutive hours after enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in